Exploring the feasibility of dose escalation positron emission tomography-positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies

Medical Dosimetry

Volumn 36, Issue 4, 2011, Pages 383-388

  Turner, Lehendrick M ^a   Howard, Joshua A ^a   Dehghanpour, Pouya ^a   Barrett, Renée D ^a   Rebueno, Neal ^a   Palmer, Matthew ^a   Vedam, Sastry ^a   Klopp, Ann ^a   Komaki, Ritsuko ^a   Welsh, James W ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Dose; Escalation; IMRT; SIB; Thoracic

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEASIBILITY STUDY; FEMALE; HUMAN; INOPERABLE CANCER; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; SIMULTANEOUS INTEGRATED BOOST; THORAX CANCER; TISSUE STRUCTURE; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80755129070     PISSN: 09583947     EISSN: 18734022     Source Type: Journal    
DOI: 10.1016/j.meddos.2010.09.007     Document Type: Article

References (19)

1. Maghfoor I., Perry M. Lung cancer, non-small cell Accessed 2005. http://emedicine.medscape.com/article/279960-overview.
2. Kong F., ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local control and overall survival in patients with inoperable/unresectable non-small cell lung cancer: long-term results of a radiation dose esculation study. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63:324-333.
3. Song Y., Muller B., Burman C. From intenisty modulated radiation therapy to 4-D radiation therapy-an advance in targeting mobile lung tumors. IEEE EMBS. 2007, 226-229.
4. Klopp A.H., Chang J.Y., Tucker S.L. Intrathoracic patterns of failure for non-small-cell-lung cancer with positron-emission tomography/computed tomography-defined target delineation. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69:1409-1416.
5. Goerres G.W., Burger C., Kamel E., et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 2003, 226:906-910.
6. Carr J.A., Silver J.M. The false assumption of lung cancer based upon a positive positron emission tomographic scan. Interact Cardiovasc. Thorac. Surg. 2006, 5:446-447.
7. Sura S., Yorke E., Jackson A. High dose radiotherapy for the treatment of inoperable non-small cell lung cancer. Cancer. J. 2007, 13:238-242.
8. Thirion P., Holmberg O., Collins C.D. Esculated dose for non-small cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy. Radiother Oncol. 2007, 71:163-166.
9. Kim Y., Tome W. Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose. Acta Oncol. 2008, 47:906-916.
10. St-Hilaire J., Sevigny C., Beaulieu F., et al. Dose escalation in the radiotherapy of non-small-cell lung cancer with apeture-based intenisty modulation and photon beam energy optimization for non-preselected patients. Radiother. Oncol. 2009, 91:342-348.
11. Hayman J.A., Martel M.K., ten Haken R.K., et al. Dose escalation in non small cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J. Clin. Oncol. 2001, 19:127-136.
12. Hayakawa K., Mitsuhashi N., Saito Y., et al. Limited field irradiation for medically inoperable patients with peripheral stage I non small cell lung cancer. Lung Cancer 1999, 76:137-142.
13. Adkinson J., Khuntia D., Bentzen S., et al. Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation. Technol. Cancer Res. Treat. 2008, 7:441-447.
14. Murshed H., Lui H.H., Liao Z., et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:1258-1267.
15. Lui H.H., Wang W., Dong L., et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:1268-1279.
16. Grills I.S., Yan D., Martinez A.A., et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell-lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2003, 57:875-890.
17. Li X., Wang J., Jursinic P., et al. Dosimetric advantages of the IMRT simultaneous integrated boost for high-risk prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 2005, 61:1251-1257.
18. Ding G., Duggan D., Coffey C., et al. A study on adaptive IMRT treatment planning using kV cone-beam CT. Radiother. Oncol. 2007, 85:116-125.
19. Le Chevalier T., Arriagada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J. Natl Cancer Inst. 1991, 83:417-423.